213 related articles for article (PubMed ID: 33705544)
21. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R
J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532
[TBL] [Abstract][Full Text] [Related]
22. Dectin-2-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy.
Ambati S; Ellis EC; Lin J; Lin X; Lewis ZA; Meagher RB
mSphere; 2019 Oct; 4(5):. PubMed ID: 31666315
[No Abstract] [Full Text] [Related]
23. Enhancing the fungicidal activity of amphotericin B via vacuole disruption by benzyl isothiocyanate, a cruciferous plant constituent.
Yamada N; Murata W; Yamaguchi Y; Fujita KI; Ogita A; Tanaka T
Lett Appl Microbiol; 2021 Apr; 72(4):390-398. PubMed ID: 33128810
[TBL] [Abstract][Full Text] [Related]
24. In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms.
Miceli MH; Bernardo SM; Lee SA
Int J Antimicrob Agents; 2009 Oct; 34(4):326-32. PubMed ID: 19515537
[TBL] [Abstract][Full Text] [Related]
25. Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts.
Spadari CC; Vila T; Rozental S; Ishida K
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844051
[No Abstract] [Full Text] [Related]
26. Susceptibility of clinical isolates of Cryptococcus neoformans to amphotericin B using time-kill methodology.
Pappalardo MC; Szeszs MW; Martins MA; Baceti LB; Bonfietti LX; Purisco SU; Baez AA; Melhem MS
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):146-51. PubMed ID: 19345042
[TBL] [Abstract][Full Text] [Related]
27. Nicotinamide potentiates amphotericin B activity against
Yan Y; Liao Z; Shen J; Zhu Z; Cao Y
Virulence; 2022 Dec; 13(1):1533-1542. PubMed ID: 36068709
[TBL] [Abstract][Full Text] [Related]
28. Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens.
Mamouei Z; Alqarihi A; Singh S; Xu S; Mansour MK; Ibrahim AS; Uppuluri P
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381356
[TBL] [Abstract][Full Text] [Related]
29. Anti-biofilm activity of a sophorolipid-amphotericin B niosomal formulation against Candida albicans.
Haque F; Sajid M; Cameotra SS; Battacharyya MS
Biofouling; 2017 Oct; 33(9):768-779. PubMed ID: 28946803
[TBL] [Abstract][Full Text] [Related]
30. Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi.
Oliver BG; Silver PM; Marie C; Hoot SJ; Leyde SE; White TC
Microbiology (Reading); 2008 Mar; 154(Pt 3):960-970. PubMed ID: 18310042
[TBL] [Abstract][Full Text] [Related]
31. In vitro interaction of antifungal and antibacterial drugs against Cryptococcus neoformans var. grubii before and after capsular induction.
Rossato L; Loreto ÉS; Venturini TP; Azevedo MI; Weiblen C; Botton SA; Santurio JM; Alves SH
Med Mycol; 2015 Nov; 53(8):885-9. PubMed ID: 26333356
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of antifungal combination against Cryptococcus spp.
Reichert-Lima F; Busso-Lopes AF; Lyra L; Peron IH; Taguchi H; Mikami Y; Kamei K; Moretti ML; Schreiber AZ
Mycoses; 2016 Sep; 59(9):585-93. PubMed ID: 27135278
[TBL] [Abstract][Full Text] [Related]
33. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.
Kuhn DM; George T; Chandra J; Mukherjee PK; Ghannoum MA
Antimicrob Agents Chemother; 2002 Jun; 46(6):1773-80. PubMed ID: 12019089
[TBL] [Abstract][Full Text] [Related]
34. In vitro synergistic effects of chlorpromazine and sertraline in combination with amphotericin B against Cryptococcus neoformans var. grubii.
Rossato L; Loreto ÉS; Zanette RA; Chassot F; Santurio JM; Alves SH
Folia Microbiol (Praha); 2016 Sep; 61(5):399-403. PubMed ID: 26847460
[TBL] [Abstract][Full Text] [Related]
35. Enhanced activity of antifungal drugs using natural phenolics against yeast strains of Candida and Cryptococcus.
Faria NC; Kim JH; Gonçalves LA; Martins Mde L; Chan KL; Campbell BC
Lett Appl Microbiol; 2011 May; 52(5):506-13. PubMed ID: 21332761
[TBL] [Abstract][Full Text] [Related]
36. The anthraquinones rubiadin and its 1-methyl ether isolated from Heterophyllaea pustulata reduces Candida tropicalis biofilms formation.
Marioni J; da Silva MA; Cabrera JL; Montoya SC; Paraje MG
Phytomedicine; 2016 Nov; 23(12):1321-1328. PubMed ID: 27765351
[TBL] [Abstract][Full Text] [Related]
37. Antimalarials and amphotericin B interact synergistically and are new options to treat cryptococcosis.
Freitas GJC; Ribeiro NQ; Gouveia-Eufrasio L; Emidio ECP; Guimarães GM; César IC; Paixão TA; Oliveira JBS; Caza M; Kronstad JW; Santos DA
Int J Antimicrob Agents; 2023 Jul; 62(1):106807. PubMed ID: 37030471
[TBL] [Abstract][Full Text] [Related]
38. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
39. Enhancement effect of N-methyl-N″-dodecylguanidine on the vacuole-targeting fungicidal activity of amphotericin B against the pathogenic fungus Candida albicans.
Yutani M; Ogita A; Usuki Y; Fujita K; Tanaka T
J Antibiot (Tokyo); 2011 Jul; 64(7):469-74. PubMed ID: 21522157
[TBL] [Abstract][Full Text] [Related]
40. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.
Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K
J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
